REINVENT Registry (Registry of the Nerve Gap Repair From Integra)

Peripheral Nerve Injuries Clinical Trial

Official title: Post-Market Clinical Follow-up Registry of Patients Requiring Nerve Gap Repair From Integra

Status Active, not recruiting

Clinical Trial Summary

This is a prospective, multi-center, observational registry designed to evaluate two of Integra's collagen nerve gap repair products (NeuraGen® Nerve Guide and NeuraGen® 3D Nerve Guide Matrix). This registry will collect data on the outcome measures throughout the follow-up period for each patient. Data will be collected per standard of care.

Clinical Trial Description

Integra NeuraGen Nerve Guide has been approved for clinical use since 2001 and has become a recognized clinical option for clinical nerve repair for the type of injuries evaluated in this registry. Integra NeuraGen Nerve Guide is used in this registry as a comparator to a next-generation advanced nerve guide, Integra NeuraGen 3D Nerve Guide Matrix, that is based on the original Integra NeuraGen Nerve Guide technology but contains a regenerative matrix in the lumen. Centers chosen for participation will be current users of Integra's collagen nerve gap repair products listed above. ;

Related Conditions & MeSH terms

• Peripheral Nerve Injuries

• NCT number: NCT05339594
• Study type: Observational [Patient Registry]
• Source: Integra LifeSciences Corporation
• Status: Active, not recruiting
• Start date: May 30, 2022
• Completion date: June 2027